Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Stem Cell Reports ; 8(1): 84-94, 2017 01 10.
Artigo em Inglês | MEDLINE | ID: mdl-28076758

RESUMO

Promoting neurogenesis is a promising strategy for the treatment of cognition impairment associated with Alzheimer's disease (AD). Ganoderma lucidum is a revered medicinal mushroom for health-promoting benefits in the Orient. Here, we found that oral administration of the polysaccharides and water extract from G. lucidum promoted neural progenitor cell (NPC) proliferation to enhance neurogenesis and alleviated cognitive deficits in transgenic AD mice. G. lucidum polysaccharides (GLP) also promoted self-renewal of NPC in cell culture. Further mechanistic study revealed that GLP potentiated activation of fibroblast growth factor receptor 1 (FGFR1) and downstream extracellular signal-regulated kinase (ERK) and AKT cascades. Consistently, inhibition of FGFR1 effectively blocked the GLP-promoted NPC proliferation and activation of the downstream cascades. Our findings suggest that GLP could serve as a regenerative therapeutic agent for the treatment of cognitive decline associated with neurodegenerative diseases.


Assuntos
Doença de Alzheimer/metabolismo , Doença de Alzheimer/psicologia , Cognição/efeitos dos fármacos , Polissacarídeos Fúngicos/farmacologia , Células-Tronco Neurais/efeitos dos fármacos , Células-Tronco Neurais/metabolismo , Reishi/química , Doença de Alzheimer/tratamento farmacológico , Animais , Proliferação de Células/efeitos dos fármacos , Autorrenovação Celular/efeitos dos fármacos , Modelos Animais de Doenças , Camundongos , Camundongos Transgênicos , Neurogênese/efeitos dos fármacos , Receptor Tipo 1 de Fator de Crescimento de Fibroblastos/genética , Receptor Tipo 1 de Fator de Crescimento de Fibroblastos/metabolismo , Transdução de Sinais/efeitos dos fármacos
3.
Sci Rep ; 6: 26999, 2016 06 15.
Artigo em Inglês | MEDLINE | ID: mdl-27301785

RESUMO

The peroxisome proliferator-activated receptor (PPAR) family plays central roles in brown adipose tissue (BAT) adipogenesis and contributes to body temperature maintenance. The transcriptional activity of PPAR family has been shown to be tightly controlled by cellular signal networks. ß-arrestins function as major secondary messengers of G protein-coupled receptors (GPCR) signaling by functional interactions with diverse proteins. Here, we report that ß-arrestin-1 knock-out mice show enhanced cold tolerance. We found that ß-arrestin-1 directly interacts with PPARα and PPARγ through a LXXXLXXXL motif, while D371 in PPARα and L311/N312/D380 in PPARγ are required for their interactions with ß-arrestin-1. Further mechanistic studies showed that ß-arrestin-1 promotes PPARα- but represses PPARγ-mediated transcriptional activities, providing potential regulatory pathway for BAT function.


Assuntos
Tecido Adiposo Marrom/fisiologia , beta-Arrestina 1/fisiologia , Motivos de Aminoácidos , Animais , Sítios de Ligação , Resposta ao Choque Frio , Feminino , Expressão Gênica , Regulação da Expressão Gênica , Cinética , Masculino , Camundongos Endogâmicos C57BL , Camundongos Knockout , PPAR alfa/química , PPAR alfa/metabolismo , PPAR gama/química , PPAR gama/metabolismo , Ligação Proteica , Domínios e Motivos de Interação entre Proteínas , Multimerização Proteica , Termogênese , beta-Arrestina 1/química
4.
J Alzheimers Dis ; 47(4): 927-37, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26401772

RESUMO

Elucidation of γ-secretase structure and dynamic conformational changes is of importance to drug discovery targeting this enzyme. Electron microscopy analyses provided important structural information, but the dynamic changes of γ-secretase in cells need to be explored further. We found that PS1 internal fluorescence resonance energy transfer (FRET) probes can incorporate into γ-secretase complex and possess secretase activity. Our results from fluorescence lifetime image microscopy (FLIM) and acceptor photobleaching FRET show different PS1 internal FRET when PS1 fluorescent probes expressed alone or with other secretase subunits Aph1aL, Nicastrin, and Pen2, indicating that PS1 internal FRET could be applied for probing conformational change of γ-secretase complex. Further, we accessed whether γ-secretase activity interfering compounds induced different conformational changes of PS1. Our results show that both γ-secretase modulators and inhibitors affect PS1 internal FRET but in different manners. These results demonstrate that FLIM and acceptor photobleaching FRET could be applied to monitor different PS1 conformational changes in γ-secretase.


Assuntos
Secretases da Proteína Precursora do Amiloide/antagonistas & inibidores , Secretases da Proteína Precursora do Amiloide/metabolismo , Transferência Ressonante de Energia de Fluorescência/métodos , Microscopia de Fluorescência/métodos , Presenilina-1/metabolismo , Inibidores de Proteases/farmacologia , Western Blotting , Linhagem Celular Transformada , Células HEK293 , Humanos , Fotodegradação , Conformação Proteica/efeitos dos fármacos
5.
PLoS One ; 9(11): e111215, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25386946

RESUMO

Alzheimer's disease (AD) is a progressive neurodegenerative disease that causes substantial public health care burdens. Intensive efforts have been made to find effective and safe disease-modifying treatment and symptomatic intervention alternatives against AD. Smart Soup (SS), a Chinese medicine formula composed of Rhizoma Acori Tatarinowii (AT), Poria cum Radix Pini (PRP) and Radix Polygalae (RP), is a typical prescription against memory deficits. Here, we assessed the efficacy of SS against AD. Oral administration of SS ameliorated the cognitive impairment of AD transgenic mice, with reduced Aß levels, retarded Aß amyloidosis and reduced Aß-induced gliosis and neuronal loss in the brains of AD mice. Consistently, SS treatment reduced amyloid-related locomotor dysfunctions and premature death of AD transgenic Drosophila. Mechanistic studies showed that RP reduced Aß generation, whereas AT and PRP exerted neuroprotective effects against Aß. Taken together, our study indicates that SS could be effective against AD, providing a practical therapeutic strategy against the disease.


Assuntos
Doença de Alzheimer/tratamento farmacológico , Neuropatias Amiloides/tratamento farmacológico , Medicina Tradicional Chinesa , Fármacos Neuroprotetores/uso terapêutico , Preparações de Plantas/uso terapêutico , Peptídeos beta-Amiloides/genética , Peptídeos beta-Amiloides/metabolismo , Animais , Células Cultivadas , Transtornos Cognitivos/tratamento farmacológico , Modelos Animais de Doenças , Drosophila , Gliose/tratamento farmacológico , Aprendizagem em Labirinto/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Neurônios/patologia , Proteínas Serina-Treonina Quinases/genética
6.
Cell Res ; 23(3): 351-65, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23208420

RESUMO

Alzheimer's disease (AD) is a progressive and complex neurodegenerative disease in which the γ-secretase-mediated amyloid-ß (Aß) pathology plays an important role. We found that a multifunctional protein, ß-arrestin1, facilitated the formation of NCT/APH-1 (anterior pharynx-defective phenotype 1) precomplex and mature γ-secretase complex through its functional interaction with APH-1. Deficiency of ß-arrestin1 or inhibition of binding of ß-arrestin1 with APH-1 by small peptides reduced Aß production without affecting Notch processing. Genetic ablation of ß-arrestin1 diminished Aß pathology and behavioral deficits in transgenic AD mice. Moreover, in brains of sporadic AD patients and transgenic AD mice, the expression of ß-arrestin1 was upregulated and correlated well with neuropathological severity and senile Aß plaques. Thus, our study identifies a regulatory mechanism underlying both γ-secretase assembly and AD pathogenesis, and indicates that specific reduction of Aß pathology can be achieved by regulation of the γ-secretase assembly.


Assuntos
Doença de Alzheimer/metabolismo , Secretases da Proteína Precursora do Amiloide/metabolismo , Peptídeos beta-Amiloides/metabolismo , Arrestinas/metabolismo , Doença de Alzheimer/genética , Secretases da Proteína Precursora do Amiloide/genética , Peptídeos beta-Amiloides/genética , Animais , Arrestinas/genética , Células Cultivadas , Ensaio de Imunoadsorção Enzimática , Imuno-Histoquímica , Camundongos , Camundongos Mutantes , Camundongos Transgênicos , Microscopia de Fluorescência , beta-Arrestinas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...